Evidence map›Paper›PMID 39815808›Full record

ArticleHaematologica2025

Ethnicity in systemic AL amyloidosis may impact risk stratification.

Jahanzaib Khwaja, Sriram Ravichandran, Oliver Cohen, Darren Foard, Ana Martinez-Naharro, Lucia Venneri, Carol Whelan, Philip N Hawkins, Julian Gillmore, Helen J Lachmann and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jahanzaib KhwajaUniversity College London Hospital, 235 Euston Rd, London NW1 2BU, London, UK. j.khwaja@nhs.net.
Sriram RavichandranUniversity College London Hospital, 235 Euston Rd, London NW1 2BU, London, UK; National Amyloidosis Centre, Royal Free London Hospital, Pond Street, London NW3 2PF, UK.
Oliver CohenNational Amyloidosis Centre, Royal Free London Hospital, Pond Street, London NW3 2PF, UK.
Darren FoardNational Amyloidosis Centre, Royal Free London Hospital, Pond Street, London NW3 2PF, UK.
Ana Martinez-NaharroNational Amyloidosis Centre, Royal Free London Hospital, Pond Street, London NW3 2PF, UK.
Lucia VenneriNational Amyloidosis Centre, Royal Free London Hospital, Pond Street, London NW3 2PF, UK.
Carol WhelanNational Amyloidosis Centre, Royal Free London Hospital, Pond Street, London NW3 2PF, UK.
Philip N HawkinsNational Amyloidosis Centre, Royal Free London Hospital, Pond Street, London NW3 2PF, UK.
Julian GillmoreNational Amyloidosis Centre, Royal Free London Hospital, Pond Street, London NW3 2PF, UK.
Helen J LachmannNational Amyloidosis Centre, Royal Free London Hospital, Pond Street, London NW3 2PF, UK.
Shameem MahmoodUniversity College London Hospital, 235 Euston Rd, London NW1 2BU, London, UK; National Amyloidosis Centre, Royal Free London Hospital, Pond Street, London NW3 2PF, UK.
Marianna FontanaNational Amyloidosis Centre, Royal Free London Hospital, Pond Street, London NW3 2PF, UK.
Ashutosh WechalekarUniversity College London Hospital, 235 Euston Rd, London NW1 2BU, London, UK; National Amyloidosis Centre, Royal Free London Hospital, Pond Street, London NW3 2PF, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39815808
PMCPMC12050936

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.